Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.
O'Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, Palacios I, Maini B, Mulukutla S, Dzavík V, Popma J, Douglas PS, Ohman M. O'Neill WW, et al. Among authors: maini b. Circulation. 2012 Oct 2;126(14):1717-27. doi: 10.1161/CIRCULATIONAHA.112.098194. Epub 2012 Aug 30. Circulation. 2012. PMID: 22935569 Clinical Trial.
Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry).
Shavelle DM, Banerjee S, Maini B, Schreiber TL, Kapasi N, O'Neill WW, Popma J, Matthews RV. Shavelle DM, et al. Among authors: maini b. Am J Cardiol. 2018 Sep 15;122(6):966-972. doi: 10.1016/j.amjcard.2018.06.013. Epub 2018 Jun 21. Am J Cardiol. 2018. PMID: 30057231 Clinical Trial.
The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure.
Vetrovec GW, Anderson M, Schreiber T, Popma J, Lombardi W, Maini B, Moller JE, Schäfer A, Dixon SR, Hall S, Ohman EM, Mindrescu C, Moses J, O'Neill W. Vetrovec GW, et al. Among authors: maini b. Am Heart J. 2018 May;199:115-121. doi: 10.1016/j.ahj.2017.09.007. Epub 2017 Sep 28. Am Heart J. 2018. PMID: 29754648 Review.
One-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.
O'Hair DP, Bajwa TK, Chetcuti SJ, Deeb GM, Stoler RC, Hebeler RF, Maini B, Mumtaz M, Kleiman NS, Reardon MJ, Li S, Adams DH, Watson DR, Yakubov SJ, Popma JJ, Petrossian G. O'Hair DP, et al. Among authors: maini b. Ann Thorac Surg. 2017 May;103(5):1392-1398. doi: 10.1016/j.athoracsur.2016.11.061. Epub 2017 Feb 24. Ann Thorac Surg. 2017. PMID: 28242075
159 results